Kenneth I. Kaitin

Insider Reports History

Entity
Individual
Location
C/O Tufts Cntr For The Study Of Drug Dev, 75 Kneeland St, Suite 1100, Boston, MA
Signature
/s/ Diantha Duvall, Attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Kenneth I. Kaitin:

Stock Role Class Num Shares Value Price $ Report Date Ownership
CURIS INC Director Non Qualified Stock Option 4.25K $49.4K $11.62 May 21, 2024 Direct

Insider Reports Filed by Kenneth I. Kaitin

Symbol Company Period Transactions Value $ Form Type Date Filed Role
CRIS CURIS INC May 21, 2024 1 $49.4K 4 May 23, 2024 Director
CRIS CURIS INC Jan 23, 2023 1 $0 4 Jan 24, 2023 Director
CRIS CURIS INC Jan 31, 2022 1 $0 4 Jan 31, 2022 Director